How much does Cerezyme cost?
The cost for Cerezyme intravenous powder for injection 400 units is around $1,817 for a supply of 1 powder for injection, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.
How much does enzyme replacement therapy cost?
Enzyme replacement therapy (ERT), the mainstay of Gaucher disease management, runs between $139,000 to more than $300,000 each year(1). Patients often encounter unexpected expenses, including fees for emergency services and travel costs, during the course of their treatment.
How much does elelyso cost?
The cost for Elelyso intravenous powder for injection 200 units is around $893 for a supply of 1 powder for injection, depending on the pharmacy you visit.
Where is Cerezyme manufactured?
Cerezyme was one of the drugs manufactured at Genzyme’s Allston, Massachusetts plant, for which production was disrupted in 2009 after contamination with Vesivirus 2017.
How does Cerezyme work?
Cerezyme is an analog of the human enzyme β-glucocerebrosidase (also called acid β-glucosidase). Cerezyme reduces the accumulation of GL-1 by cleaving the substrate into glucose and ceramide.
What is Cerezyme used for?
Imiglucerase is used to treat a certain rare genetic problem (Gaucher disease). Imiglucerase replaces a certain natural substance (an enzyme called glucocerebrosidase) that is missing in people with Gaucher disease. This medication improves blood, bone, liver, and spleen problems caused by Gaucher disease.
How is vpriv made?
VPRIV is made in a human cell line using Shire’s gene activation technology. The enzyme produced has the exact human amino acid sequence as that found in the naturally occurring human enzyme. VPRIV is used for the long-term treatment of patients with type 1 Gaucher disease.
Is Cerezyme a biologic?
Cerezyme is a biologic therapy that is indicated to treat: pediatric and adult patients with a confirmed diagnosis of Type 1 Gaucher disease that results in one or more of the following conditions: anemia. thrombocytopenia. bone disease.
When was Cerezyme FDA?
Since the approval of Cerezyme® (imiglucerase for injection) in May 1994, Genzyme has maintained a worldwide post-marketing database of spontaneously reported adverse events and adverse events discussed in the medical literature.
Who makes Cerezyme?
To report SUSPECTED ADVERSE REACTIONS, contact Sanofi Medical Information at 1-800-745-4447, Option 2.
How is Cerezyme made?
Cerezyme® is produced by recombinant DNA technology using mammalian cell culture (Chinese hamster ovary). Purified imiglucerase is a monomeric glycoprotein of 497 amino acids, containing 4 N-linked glycosylation sites (Mr = 60,430).
How do you mix Cerezyme?
- Reconstitution using sterile water.
- Remove the flip-off cap from the Cerezyme vial.
- Dilution in 0.9% NaCl.
- Disinfect the cap/opening of 1 or 2 bags of NaCl 0.9% solution using chlorhexidine and allow to air dry.
- Administration.
- The Cerezyme dose and infusion rate will be determined by the treating physician.
How long is enzyme replacement therapy?
ERT is a life-long therapy, and each infusion takes 3 to 4 h depending on the enzyme and the dose (Table 1). There is the potential for severe infusion reactions; life-threatening anaphylaxis has rarely occurred in patients receiving ERT [12].
Who manufactures vpriv?
Velaglucerase alfa, sold under the brand name Vpriv and manufactured by Shire plc, is a hydrolytic lysosomal glucocerebroside-specific enzyme, which is a recombinant form of glucocerebrosidase indicated as a long-term enzyme replacement therapy for those suffering of Gaucher disease Type 1.
Is vpriv made from human ovaries?
Currently, three approved ERTs exist for Gaucher disease, Sanofi’s Cerezyme, which is made from Chinese hamster ovary (CHO) cells, Pfizer’s Elelyso, which is made using carrot cells, and Vpriv by Shire (now Takeda), which is produced in a human fibroblast cell line.